Related Experiment Video

Updated: Jun 15, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Mycoplasma pneumoniae as a cause of non-resolving pneumonia in a neonate

Surinder Kumar1, Arti Maria2, Sanjeev R Saigal1

  • 1Department of Microbiology, Maulana Azad Medical College, New Delhi 110002, India.

Journal of Medical Microbiology
|February 27, 2010
PubMed

Insights

Mycoplasma pneumoniae rarely causes pneumonia in infants. This case highlights persistent pneumonia due to M. pneumoniae in a 3-week-old neonate, expanding understanding of this pathogen in early life.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatology

Background:

  • Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children aged 5-15 years.
  • The role of M. pneumoniae as an etiological agent in neonatal pneumonia is infrequently documented.
  • Understanding atypical pneumonia pathogens in neonates is crucial for timely diagnosis and treatment.

Observation:

  • A 3-week-old neonate presented with persistent pneumonia.
  • Standard diagnostic approaches were employed to identify the causative agent.
  • Clinical presentation suggested an atypical pneumonia etiology.

Findings:

  • Mycoplasma pneumoniae was identified as the causative organism.
  • This diagnosis was confirmed through appropriate laboratory testing.
  • The neonate experienced persistent pneumonia attributed to M. pneumoniae.

Implications:

  • This case expands the known spectrum of M. pneumoniae infections in neonates.
  • It underscores the importance of considering M. pneumoniae in persistent neonatal pneumonia.
  • Further research may elucidate the specific risk factors and clinical characteristics of M. pneumoniae in this age group.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: